Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 191
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and...
Psychedelic Research Bulletin: May 2022
PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted...
Psychedelic Bulletin #104 – Mydecine CEO Downplays Insider Activity; UC Davis...
PT322 – Kimberly Juroviesky, Capt, USAF, Retired – Ketamine and...
Conflicting States of Consciousness: Exploring Psilocin and Sleep
Oregon, Measure 109, and Religious Freedom: The Final Vote
PT321 – Lyle Maxson – Virtual Reality, Biofeedback, and Digital Therapeutics:...
Psychedelic Bulletin #103 – MAPS Phase 3 Trial On Schedule;...
PT320 – Anne Philippi – The New Health Club, Intergenerational Trauma,...
Load more